India's No.1 PU & Degree With Integrated IAS & IPS(UPSC/PSC) Training College.
GEMCOVAC –OM Vaccine : Approved
News: The Drug Controller General of India approved GEMCOVAC-OM, India’s first locally produced mRNA vaccine, for use in emergency situations.
Gennova Biopharmaceuticals Ltd. created the GEMCOVAC-OM vaccine with the help of the Mission COVID Suraksha programme, which is run by the Biotechnology Industry Research Assistance Council (BIRAC).
It is a thermostable vaccine, making distribution across India simple. It does not require the ultra-cold chain infrastructure needed for other authorised mRNA-based vaccines.
Using a system of needle-free injection devices, it is administered intradermally.
Participants received it intradermally as a booster, and the immune responses were noticeably enhanced.
The clinical outcome shows that variant-specific vaccinations are required to elicit the desired immune response.
A single-stranded RNA molecule that complements DNA is messenger RNA (mRNA), which is present in the mRNA vaccination.
Pre-mRNA is produced in the nucleus when DNA is translated by RNA polymerase.
